Afficher la couverture 'MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations | Antony-Debré, Iléana' en grand format
/5

0 avis

MYH10 protein expression in platelets as a biomarker of RUNX1 and FLI1 alterations

Archive ouverte

Antony-Debré, Iléana | Bluteau, Dominique | Itzykson, Raphael | Baccini, Véronique | Renneville, Aline | Boehlen, Françoise | Morabito, Margot | Droin, Nathalie | Deswarte, Caroline | Chang, Yunhua | Leverger, Guy | Solary, Eric | Vainchenker, William | Favier, Rémi | Raslova, Hana

Edité par CCSD ; American Society of Hematology -

International audience. Abstract RUNX1 gene alterations are associated with acquired and inherited hematologic malignancies that include familial platelet disorder/acute myeloid leukemia, primary or secondary acute myeloid leukemia, and chronic myelomonocytic leukemia. Recently, we reported that RUNX1-mediated silencing of nonmuscle myosin heavy chain IIB (MYH10) was required for megakaryocyte ploidization and maturation. Here we demonstrate that runx1 deletion in mice induces the persistence of MYH10 in platelets, and a similar persistence was observed in platelets of patients with constitutional (familial platelet disorder/acute myeloid leukemia) or acquired (chronic myelomonocytic leukemia) RUNX1 mutations. MYH10 was also detected in platelets of patients with the Paris-Trousseau syndrome, a thrombocytopenia related to the deletion of the transcription factor FLI1 that forms a complex with RUNX1 to regulate megakaryopoiesis, whereas MYH10 persistence was not observed in other inherited forms of thrombocytopenia. We propose MYH10 detection as a new and simple tool to identify inherited platelet disorders and myeloid neoplasms with abnormalities in RUNX1 and its associated proteins.

Consulter en ligne

Suggestions

Du même auteur

Level of RUNX1 activity is critical for leukemic predisposition but not for thrombocytopenia

Archive ouverte | Antony-Debré, Iléana | CCSD

International audience. A half loss of RUNX1 activity leads to defects in primitive erythropoiesis, megakaryopoiesis, and proplatelet formation. • An almost complete loss of RUNX1 activity leads to the amplification...

Acquired TET2 mutation in one patient with familial platelet disorder with predisposition to AML led to the development of pre-leukaemic clone resulting in T2-ALL and AML-M0

Archive ouverte | Manchev, Vladimir T. | CCSD

International audience. Familial platelet disorder with predisposition to acute myeloid leukaemia (FPD/AML) is characterized by germline RUNX1 mutations, thrombocy-topaenia, platelet dysfunction and a risk of develo...

Thrombocytopenia-associated mutations in the ANKRD26 regulatory region induce MAPK hyperactivation

Archive ouverte | Bluteau, Dominique | CCSD

International audience. Point mutations in the 5′ UTR of ankyrin repeat domain 26 (ANKRD26) are associated with familial throm-bocytopenia 2 (THC2) and a predisposition to leukemia. Here, we identified underlying me...

Chargement des enrichissements...